November 10th 2024
Based on their findings, the researchers suggest a potential need for screening for coexisting sleep disorder symptoms in patients with respiratory symptoms.
Assessing the Treatment Landscape for Multiple Sclerosis to Better Individualize Care
Exploring Transthyretin-Mediated Amyloidosis and Its Phenotypes: A Comprehensive Approach to Patient Treatment
The Role of the Specialty Pharmacist in Optimizing Treatment for Amyotrophic Lateral Sclerosis: The Impact of Early Intervention, Patient-Centered Care, and Disease-Modifying Therapies in Slowing Disease Progression
Advancing Targeted Therapies Aimed at Smoldering Disease in Multiple Sclerosis
The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation
Managing Patients With COPD: Evidence-Based Care and Optimizing Value of New and Emerging Targeted Therapies
Understanding the Relationship Between Sleep Apnea, Atrial Fibrillation
Dr Susan Millard on Assessment, Treatment Process of Pediatric OSA
How Do Anxiety, Depression Affect Severity of Obstructive Sleep Apnea?